GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Veradigm MDRX · USD

Health Care · US listing · 🇺🇸 United States

Compare

4.75

-1.04%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2024

Revenue

$588.0m

FY2014FY2024

Net income

−$86.5m

FY2014FY2024

Free cash flow

$83.3m

FY2014FY2024

Shareholders' equity

$1.02bn

FY2014FY2024

Income statement

Fiscal years

FY2024FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue$588.0m$588.0m$577.4m$1.50bn$1.63bn$1.75bn$1.50bn$1.55bn$1.39bn$1.38bn
Gross profit$308.4m$308.4m$258.2m$565.7m$574.5m$724.5m$632.8m$645.0m$557.4m$546.0m
Research and development$97.9m$97.9m$84.8m$206.1m$254.5m$295.8m$220.2m$188.1m$184.8m$192.8m
Operating income−$27.1m−$19.6m$75.7m−$57.7m−$99.7m−$95.1m$12.5m$67.7m$31.9m−$39.2m
Net income−$86.5m−$86.5m$134.4m$700.4m−$182.2m$363.7m−$196.5m−$25.7m−$2.2m−$66.5m
Diluted earnings per share-0.67-0.771.124.64-1.112.07-1.09-0.14-0.01-0.37

Balance sheet

At each fiscal year end

FY2024FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assets$1.50bn$1.50bn$2.43bn$2.92bn$3.21bn$3.18bn$4.23bn$3.83bn$2.68bn$2.46bn
Cash and short-term investments$446.6m—$188.3m$531.1m$129.7m$174.2m$119.5m$95.6m$116.9m$53.2m
Total liabilities$487.2m$487.2m$1.02bn$1.25bn$1.92bn$1.60bn$2.64bn$2.17bn$1.26bn$1.18bn
Debt$219.4m$200.4m$372.9m$283.3m$1.03bn$669.4m$937.9m$1.33bn$625.0m$566.7m
Shareholders' equity$1.02bn$1.02bn$1.41bn$1.67bn$1.29bn$1.58bn$1.12bn$1.23bn$1.42bn$1.28bn
Shares outstanding129m112m120m151m164m175m181m183m192m180m

Cash flow

Fiscal years

FY2024FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations$115.6m$115.6m−$75.4m−$106.7m$46.3m$67.9m$279.4m$269.0m$211.6m$103.5m
Capital spending−$32.3m−$32.3m−$1.9m−$17.0m−$128.0m−$144.6m−$157.0m−$137.9m−$67.6m−$67.1m
Free cash flow$83.3m$83.3m−$77.3m−$123.7m−$81.7m−$76.7m$122.4m$131.1m$144.0m$36.4m
Dividends paid—————−$580.2m−$374.7m−$1.16bn——

Latest quarters

By quarter end

Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020
Revenue$151.9m$150.9m$142.7m$391.7m$369.3m$373.7m$368.4m$277.7m
Gross profit$83.4m$79.5m$73.5m$169.0m$293.9m$140.7m$138.1m$82.7m
Operating income$25.0m−$5.4m$6.6m$41.4m$18.5m$16.8m$7.7m−$143.0m
Net income$9.4m−$64.0m$22.9m$87.3m$16.2m$21.9m$9.1m$727.8m
Diluted earnings per share0.08-0.570.200.730.130.180.084.82
Cash from operations$28.0m−$1.0m$69.0m$65.0m$55.0m−$200.0m$4.0m−$178.0m
Capital spending−$8.0m−$9.0m−$9.0m−$18.0m−$10.0m−$8.0m−$8.0m−$19.0m
Free cash flow$20.0m−$10.0m$60.0m$47.0m$45.0m−$208.0m−$4.0m−$197.0m
Total assets$1.69bn$1.71bn$2.43bn$2.43bn$2.48bn$2.54bn$2.87bn$2.92bn
Cash and short-term investments$492.6m$500.2m$82.8m$188.4m$214.2m$229.3m$513.4m$531.1m
Debt$206.5m$206.0m$389.0m$375.8m$392.5m$441.0m$192.0m$189.9m
Shareholders' equity$1.18bn$1.20bn$1.35bn$1.41bn$1.42bn$1.39bn$1.68bn$1.67bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-26.9%-19.6%-8.1%
Operating income-22.2%-22.2%-14.4%
Net income——-1.8%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin52.5%44.2%41.3%40.9%
Operating margin-4.0%-0.9%-3.4%-2.0%
Net margin-14.7%20.3%12.7%3.2%

Valuation history

At each fiscal year end

FY2024FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Price to earnings-14.5-22.916.53.1-8.84.7-13.4-72.9-1323.1-34.6
Price to sales2.13.43.81.41.01.01.81.22.11.7

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-50%-1%-45%-4%33%42%2%-34%42%-28%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.